Tweet
<img alt="" height="1" width="1" />
Pharmasset Rises After Hepatitis Drug Shows 100% Cure Rate
BusinessWeek
Nov. 7 (Bloomberg) -- Pharmasset Inc. rose as much as 16 percent in early trading after the company said its experimental drug for treating hepatitis C cured all patients in a study. Shares of the Princeton, New Jersey-based ...
Pharmasset Rises After Hepatitis Drug Shows 100% Cure RateBloomberg
On a roll, Pharmasset outlines 100% cure rate for hot hep C programFierceBiotech
Pharmasset (VRUS) Shares Given New $77.00 Price Target by Goldman Sachs (GS ...LocalizedUSA
Market Intelligence Center -AIDSmeds.com HIV/AIDS Treatment News -StreetInsider.com (subscription)
all 11 news articles »
More...